LEDERMAN SETH 4
4 · Tonix Pharmaceuticals Holding Corp. · Filed Feb 17, 2022
Insider Transaction Report
Form 4
LEDERMAN SETH
DirectorChief Executive Officer
Transactions
- Award
Stock Option
2022-02-15+5,000,000→ 5,000,000 totalExercise: $0.83From: 2023-02-15Exp: 2032-02-15→ Common Stock (5,000,000 underlying) - Award
Stock Option
2022-02-15+5,000,000→ 5,000,000 totalExercise: $0.21From: 2023-02-15Exp: 2032-02-15→ Common Stock (5,000,000 underlying) - Award
Stock Option
2022-02-15+5,000,000→ 5,000,000 totalExercise: $0.41From: 2023-02-15Exp: 2032-02-15→ Common Stock (5,000,000 underlying) - Award
Stock Option
2022-02-15+5,000,000→ 5,000,000 totalExercise: $0.62From: 2023-02-15Exp: 2032-02-15→ Common Stock (5,000,000 underlying)
Footnotes (3)
- [F1]One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
- [F2]10% of the option vests on the first anniversary of issuance, 10% on the second anniversary of issuance, 40% on the third anniversary of issuance, and 40% on the fourth anniversary of issuance.
- [F3]The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.